Insider · CIK 0001920780
Ramnik Xavier
Files at MLTX (MoonLake Immunotherapeutics). First filing -, latest -.
In brief
Ramnik Xavier files SEC Form 4 as director at MLTX (MoonLake Immunotherapeutics). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ramnik Xavier has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | MLTX MoonLake Immunotherapeutics | AGrant or award Option to Buyderivative | +22,195 | $0.00 | $0 | 22,195 | Jun 18, 2026 |
| Jun 5, 2025 | MLTX MoonLake Immunotherapeutics | AGrant or award Option to Buyderivative | +6,682 | $0.00 | $0 | 6,682 | Jun 9, 2025 |
Questions about Ramnik Xavier
Answered from the filings on this page, as of the latest one.
Is Ramnik Xavier buying or selling?
Ramnik Xavier has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ramnik Xavier's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ramnik Xavier has 0.
Where does Ramnik Xavier file Form 4?
Ramnik Xavier has filed Form 4 at MLTX (MoonLake Immunotherapeutics). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.